Grant: Fellowship - PA: Micronutrients and Dietary Bioactives (SHOPP)
University of Alberta
$67,500.00
The impact of antibiotic use, caesarean section delivery and formula feeding on infant microbiota
EF 2010-11
Résumé
Bacteria living in the digestive tract (known as microbiota) play a crucial role in immunity. Alteration of infant microbiota has the potential to cause disease later in childhood. Antibiotic use, infant diet and birth mode are known to significantly affect infant microbiota. These exposures are also important risk factors for allergy and asthma in children. The impact of antibiotic-mediated microbiota disturbance is poorly understood because infants receiving antibiotics are often excluded from studies. This limits our ability to inform clinicians and parents about the consequences of treating infants with antibiotics.
Our goal is to systematically investigate the impact of antibiotic use, mode of delivery and diet on infant microbiota. We will employ the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study as a research platform. Antibiotic prescription use will be detailed from provincial database records. Mode of delivery will be extracted from hospital records. Maternal exposures during pregnancy and type of infant feeding will be obtained from parent report. Microbiota profiles will be generated via genetic analysis of infant fecal samples. We will employ statistical methods to test for the individual and combined effects of the following risk factors on microbiota diversity: antibiotic use (in mothers and infants), mode of delivery (vaginal or caesarean section), and infant diet (breast or formula-feeding).
In most Western countries, the rate of caesarean delivery is increasing, breastfeeding rates are lower than recommended, and almost two-thirds of infants will be prescribed an antibiotic by one year of age. Accumulating evidence suggests that these factors impact significantly on infant microbiota and subsequent development of allergy and asthma. Our research aims to provide evidence for a true causal relationship, with the potential to impact clinical practice guidelines in antibiotic use, breast feeding and caesarean section.
Programme
Fellowship - PA: Micronutrients and Dietary Bioactives (SHOPP)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
215932
Name
Azad Meghan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
The Centrum Foundation (Mississauga, ON); Canadian Nutrition Society (Ottawa, Ontario)
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
The impact of antibiotic use, caesarean section delivery and formula feeding on infant microbiota
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
Fellowship - PA: Micronutrients and Dietary Bioactives (SHOPP)
Keyworddelim
Antibiotic Use; Atopic Disease; Bioinformatics; Breastfeeding; Caesarian Section; Environmental Influences On Health; Epidemiology; Gut Dysbiosis; Immune Development; Infant Microbiota
Abstract
Bacteria living in the digestive tract (known as microbiota) play a crucial role in immunity. Alteration of infant microbiota has the potential to cause disease later in childhood. Antibiotic use, infant diet and birth mode are known to significantly affect infant microbiota. These exposures are also important risk factors for allergy and asthma in children. The impact of antibiotic-mediated microbiota disturbance is poorly understood because infants receiving antibiotics are often excluded from studies. This limits our ability to inform clinicians and parents about the consequences of treating infants with antibiotics.
Our goal is to systematically investigate the impact of antibiotic use, mode of delivery and diet on infant microbiota. We will employ the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study as a research platform. Antibiotic prescription use will be detailed from provincial database records. Mode of delivery will be extracted from hospital records. Maternal exposures during pregnancy and type of infant feeding will be obtained from parent report. Microbiota profiles will be generated via genetic analysis of infant fecal samples. We will employ statistical methods to test for the individual and combined effects of the following risk factors on microbiota diversity: antibiotic use (in mothers and infants), mode of delivery (vaginal or caesarean section), and infant diet (breast or formula-feeding).
In most Western countries, the rate of caesarean delivery is increasing, breastfeeding rates are lower than recommended, and almost two-thirds of infants will be prescribed an antibiotic by one year of age. Accumulating evidence suggests that these factors impact significantly on infant microbiota and subsequent development of allergy and asthma. Our research aims to provide evidence for a true causal relationship, with the potential to impact clinical practice guidelines in antibiotic use, breast feeding and caesarean section.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Azad, Meghan
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $22,500~ $0~SPIR~ $45,000~ $0~